Related Experiment Videos
Pulmonary disease in Behçet's syndrome
The Quarterly Journal of Medicine
|March 1, 1986
Summary
Behçet's syndrome can cause severe pulmonary disease with haemoptysis, a serious condition with a poor prognosis. Early diagnosis and treatment are crucial for managing this rare but life-threatening manifestation.
Area of Science:
- Rheumatology
- Pulmonology
- Immunopathology
Background:
- Behçet's syndrome is a multisystem vasculitis.
- Pulmonary involvement is a rare but serious complication.
Observation:
- A review of 28 cases of Behçet's syndrome with haemoptysis revealed a distinct clinical pattern.
- Haemoptysis, often with pyrexia, chest pain, and dyspnoea, was the predominant symptom.
- Pulmonary disease frequently co-occurred with active disease in other sites, though haemoptysis was the main complaint.
Findings:
- Patients with Behçet's syndrome and haemoptysis showed a male predominance and higher rates of thrombophlebitis and deep vein thrombosis.
- Pulmonary vasculitis, potentially driven by immune complexes, underlies the pathogenesis, leading to thrombosis, infarction, haemorrhage, and aneurysms.
- Corticosteroids and anticoagulants had limited efficacy in severe cases, with pulmonary haemorrhage being a frequent cause of death.
Implications:
- Pulmonary disease with haemoptysis carries a grave prognosis in Behçet's syndrome.
- Accurate diagnosis and timely, appropriate treatment are imperative.
- Pulmonary disease with haemoptysis should be considered a minor diagnostic criterion for Behçet's syndrome.